An elderly woman with no known cardiovascular issues is seen for acute onset palpitations, dyspnea, and chest pain.
What drug has shown survival benefit greater than 3 months in high-risk PAH patients? Select your answer and move to the next question.
Together these characteristics and insights compose an engaging snapshot of the current state of cardiology.
The practice of CVD risk estimation shifted radically in 2013. The ACC-AHA app helps you connect the new dots.